Department of Clinical Pharmacy, Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia.
Curr Pharm Des. 2024;30(40):3175-3189. doi: 10.2174/0113816128306956240801052553.
The current investigation involved the development and application of a topical treatment for wound healing for sesamol loaded into the silver nanoparticles (SML-AgNPs).
SML-AgNPs were produced through the application of microwave technique. The SML-AgNPs were further optimized utilizing a Box-Behnken design (BBD).
The Opt-SML-AgNPs formulation that was optimized demonstrated a particle size of 160.49 ± 1.11 nm, a polydispersity index (PDI) of 0.241 ± 0.54, a zeta potential of -21.09 ± 0.88 mV, and an efficiency of 84.19 ± 1.19%. The morphology of the Opt-SML-AgNPs reveals a spherical structure. The Opt-SML-AgNPs exhibit a higher drug release rate as compared to the SML suspension. The Opt-SML-AgNPs were incorporated into the carbopol gel (Opt-SML-AgNPG) and evaluated for various parameters. The skin permeation investigation revealed a twofold increase for the Opt-SML-AgNPG formulation when compared to the SML-conventional gel formulation. This finding indicates a prolonged release pattern and an enhanced permeability profile. The Opt-SML-AgNPs formulation exhibited a higher level of antioxidant activity when compared to the SML solution which is beneficial for wound healing.
In conclusion, the Opt-SML-AgNPG exhibits considerable potential in effectively penetrating the deeper dermal layers. Therefore, it may be considered that they possess the potential to serve as a suitable nanocarrier to administer topical delivery in the context of treating skin-related illnesses.
本研究涉及将载有芝麻酚的银纳米粒子(SML-AgNPs)制成局部伤口愈合治疗剂。
采用微波技术制备 SML-AgNPs,并用 Box-Behnken 设计(BBD)对 SML-AgNPs 进行进一步优化。
优化后的 Opt-SML-AgNPs 制剂的粒径为 160.49±1.11nm,多分散指数(PDI)为 0.241±0.54,zeta 电位为-21.09±0.88mV,效率为 84.19±1.19%。Opt-SML-AgNPs 的形态呈球形结构。Opt-SML-AgNPs 显示出比 SML 悬浮液更高的药物释放率。Opt-SML-AgNPs 被掺入卡波姆凝胶(Opt-SML-AgNPG)中,并对各种参数进行了评估。皮肤渗透研究表明,与 SML 常规凝胶制剂相比,Opt-SML-AgNPG 制剂的渗透量增加了一倍。这表明存在延长的释放模式和增强的渗透特性。与 SML 溶液相比,Opt-SML-AgNPs 制剂表现出更高的抗氧化活性,这有利于伤口愈合。
总之,Opt-SML-AgNPG 具有有效穿透更深真皮层的潜力。因此,可以认为它们具有作为合适的纳米载体的潜力,可用于通过局部递送来治疗皮肤相关疾病。